EI
DERM icon

EAM Investors’s Journey Medical DERM Stock Holding History

EAM Investors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-89,389
Closed -$689K – 300
2025
Q4 		$689K Hold
89,389
– – 0.08% 242
2025
Q3 		$636K Sell
89,389
-5,678
-6% -$41.2K 0.07% 240
2025
Q2 		$683K Buy
+95,067
New +$657K 0.1% 189
2024
Q1 		– Sell
-110,509
Closed -$637K – 264
2023
Q4 		$637K Buy
+110,509
New +$492K 0.11% 208

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors's DERM Position: Q1 2026 in Review

EAM Investors sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 89,389 shares — an estimated $689K sold.

EAM Investors first reported a position in DERM in Q4 2023 and held it in 4 quarters. The position peaked at $689K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • EAM Investors reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • EAM Investors sold 89,389 Journey Medical shares in Q1 2026, an estimated $689K.
  • EAM Investors first reported a position in Journey Medical in Q4 2023 and held it in 4 quarters.
  • EAM Investors's Journey Medical position peaked at $689K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.